Fig. 2. H&E staining of the retina for the counting of neovascular lumens in each group. Numerous neovascular lumens were observed in the sham-treated group (A). There was a significant reduction in the number of neovascular lumens in both the low- (B) and high-dose (C) sulodexide groups compared to the control group (P ＜ 0.05). Sulodexide significantly reduced the number of vascular lumens in comparison to sham treatment (D). Arrows indicate the vascular lumens of new vessels growing into the vitreous. Data shown are the mean ± SD; lumens were counted at ×40 magnification. Scale bars: 50 μm.